Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Hypolipidemia is associated with the severity of COVID-19251
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction103
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group70
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials70
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association68
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient55
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy50
Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability49
The association between triglycerides and incident cardiovascular disease: What is “optimal”?42
Ketogenic diets, not for everyone38
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)38
A simplified diagnosis algorithm for dysbetalipoproteinemia37
PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study36
Saturated fats and cardiovascular health: Current evidence and controversies36
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment33
Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial32
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association24
Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching22
HDL proteome remodeling associates with COVID-19 severity22
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial21
A catalog of the pathogenic mutations of LDL receptor gene in Japanese familial hypercholesterolemia21
0.09230899810791